Armistice Capital, LLC Reviva Pharmaceuticals Holdings, Inc. Call Options Transaction History
Armistice Capital, LLC
- $7.08 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RVPH
# of Institutions
51Shares Held
7.83MCall Options Held
628KPut Options Held
338K-
Israel Englander Millennium Management LLC | New York, Ny1.8MShares$2.89 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$2.22 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.06MShares$1.69 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT514KShares$822,8360.13% of portfolio
-
Geode Capital Management, LLC Boston, MA312KShares$498,7210.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $32.7M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...